Atlas Trials

A Long-Term Treatment Study of ACH-0144471 in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Clinical trial NCT03181633 · COMPLETED

Trial details

NCT number
NCT03181633
Sponsor
Alexion Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Paroxysmal Nocturnal Hemoglobinuria
Start date
2017-06-22
Primary completion
2022-01-04
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.